How is the BioNTech SE - ADR today?

The BioNTech SE - ADR today is trading in the green, up by 2.04% at 106.53.

How has BioNTech SE - ADR performed historically?

The BioNTech SE - ADR is currently trading up 2.04% on an intraday basis in the past week the index fell -0.04%. The index has been up 11.69% in the past quarter and rose 25.86% in the past year. You can view this in the overview section.

What is BioNTech SE - ADR Annual Revenue?

BioNTech SE - ADR Annual Revenue fell 27.96%, in the last year to $2,751.1 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is BioNTech SE - ADR Annual Net Profit?

BioNTech SE - ADR Annual Net Profit fell 171.51% in the last year to $665.3 M. Its sector's average net profit growth for the last fiscal year was -14.05%.

What is BioNTech SE - ADR Price to Earning Ratio?

BioNTech SE - ADR Price to Earning Ratio is -29.01, which is negative.

What is BioNTech SE - ADR Stock Price?

BioNTech SE - ADR Stock Price rose 25.86% and underperformed its sector by 129.37% in the past year.

What is BioNTech SE - ADR Quarterly Revenue?

BioNTech SE - ADR Quarterly Revenue fell 2.56% YoY to $182.8 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is BioNTech SE - ADR Quarterly Net profit?

BioNTech SE - ADR Quarterly Net profit fell 31.96% YoY to $415.8 M. Its sector's average net profit growth YoY for the quarter was -236.06%.

What is BioNTech SE - ADR Debt to Equity Ratio?

BioNTech SE - ADR Debt to Equity Ratio of 0.01 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is BioNTech SE - ADR Return on Equity(ROE)?

BioNTech SE - ADR Return on Equity(ROE) for the last financial year was -3.36%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is BioNTech SE - ADR Mutual Fund Holding?

BioNTech SE - ADR Mutual Fund Holding increased by 0.57% in the last quarter to 28.47.

What is BioNTech SE - ADR Interest Coverage Ratio?

BioNTech SE - ADR Interest Coverage Ratio is -52.79, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is BioNTech SE - ADR Institutional Holding?

BioNTech SE - ADR Institutional Holding increased by 0.43% in the last quarter to 21.8.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : BIOTECH
BIONTECH SE - ADR

BioNTech SE - ADR XNAS: BNTX

BioNTech SE - ADR Live Share Price Today, Share Analysis and Chart

Name: BioNTech SE - ADR: Is Infosys Ltd. worth buying?
Item: BioNTech SE - ADR
Rating: 1.482027875
Author: Trendlyne DVM scores

Momentum Trap

about

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several c...

106.53 2.13 (2.04%)

39.20% Gain from 52W Low

721.5K

XNAS Volume

XNAS 20 Jun, 2025 5:30 PM (EDT)

Low Financial Strength

27.8 / 100

Expensive Valuation

19.7 / 100

Technically Neutral

43.3 / 100

Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

135

1Yr Price target upside is 27%

21 analysts

BioNTech SE - ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

BioNTech SE - ADR Live Share Price Today, Share Analysis and Chart

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several c...

39.20% Gain from 52W Low

BioNTech SE - ADR Live Price Chart

BioNTech SE - ADR FAQ

How is BioNTech SE - ADR today?

BioNTech SE - ADR today is trading in the green, and is up by 2.04% at 106.53.

How has BioNTech SE - ADR performed historically?

BioNTech SE - ADR is currently trading up 2.04% on an intraday basis. In the past week the stock fell -0.04%. stock has been up 11.69% in the past quarter and rose 25.86% in the past year. You can view this in the overview section.